BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hongsrichan N, Rucksaken R, Chamgramol Y, Pinlaor P, Techasen A, Yongvanit P, Khuntikeo N, Pairojkul C, Pinlaor S. Annexin A1: A new immunohistological marker of cholangiocarcinoma. World J Gastroenterol 2013; 19(16): 2456-2465 [PMID: 23674846 DOI: 10.3748/wjg.v19.i16.2456]
URL: https://www.wjgnet.com/1007-9327/full/v19/i16/2456.htm
Number Citing Articles
1
Lu Guo, Caixia Zhang, Jinghong Zhu, Yuqin Yang, Jianfa Lan, Gang Su, Xiaodong Xie. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancerLife Sciences 2016; 151: 102 doi: 10.1016/j.lfs.2016.03.006
2
Janesly Prates, Jusciéle Brogin Moreli, Alexandre Dantas Gimenes, Joice Matos Biselli, Solange Correa Garcia Pires D’Avila, Silvana Sandri, Sandra Helena Poliselli Farsky, Flávia Cristina Rodrigues-Lisoni, Sonia Maria Oliani. Cisplatin treatment modulates Annexin A1 and inhibitor of differentiation to DNA 1 expression in cervical cancer cellsBiomedicine & Pharmacotherapy 2020; 129: 110331 doi: 10.1016/j.biopha.2020.110331
3
Jian Zhang, Huiwen Wang, Jinqing Liu, Lei Fu, Shifang Peng. ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitisHuman Genomics 2023; 17(1) doi: 10.1186/s40246-023-00534-z
4
Juliet Padden, Maike Ahrens, Julia Kälsch, Stefanie Bertram, Dominik A. Megger, Thilo Bracht, Martin Eisenacher, Peri Kocabayoglu, Helmut E. Meyer, Bence Sipos, Hideo A. Baba, Barbara Sitek. Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected CellsMolecular & Cellular Proteomics 2016; 15(3): 1072 doi: 10.1074/mcp.M115.054585
5
Qing-Hua Liu, Mei-Lin Shi, Jin Bai, Jun-Nian Zheng. Identification of ANXA1 as a Lymphatic Metastasis and Poor Prognostic Factor in Pancreatic Ductal AdenocarcinomaAsian Pacific Journal of Cancer Prevention 2015; 16(7): 2719 doi: 10.7314/APJCP.2015.16.7.2719
6
Rohit Bavi, Zhang Hang, Parikshit Banerjee, Md Aquib, Mahendra Jadhao, Niraj Rane, Sneha Bavi, Raghunath Bhosale, Kisan Kodam, Byong-Hun Jeon, Yueqing Gu. Doxorubicin-Conjugated Innovative 16-mer DNA Aptamer-Based Annexin A1 Targeted Anti-Cancer Drug DeliveryMolecular Therapy - Nucleic Acids 2020; 21: 1074 doi: 10.1016/j.omtn.2020.07.038
7
Zhenghui Song, Xue Wang, Xinhui Liu, Yue Luo, Jieya Qiu, Aiqi Yin, Yun Liu, Hong Yi, Zhiqiang Xiao, Aimin Li. Targeting of Annexin A1 in Tumor-associated Macrophages as a therapeutic strategy for hepatocellular carcinomaBiochemical Pharmacology 2023; 213: 115612 doi: 10.1016/j.bcp.2023.115612
8
Nuttanan Hongsrichan, Kitti Intuyod, Porntip Pinlaor, Jarinya Khoontawad, Puangrat Yongvanit, Chaisiri Wongkham, Sittiruk Roytrakul, Somchai Pinlaor, J. A. Appleton. Cytokine/Chemokine Secretion and Proteomic Identification of Upregulated Annexin A1 from Peripheral Blood Mononuclear Cells Cocultured with the Liver Fluke Opisthorchis viverriniInfection and Immunity 2014; 82(5): 2135 doi: 10.1128/IAI.00901-13
9
Sok Lin Foo, Gracemary Yap, Jianzhou Cui, Lina H.K. Lim. Annexin-A1 – A Blessing or a Curse in Cancer?Trends in Molecular Medicine 2019; 25(4): 315 doi: 10.1016/j.molmed.2019.02.004
10
Ya Lin, Guoqing Lin, Wenzheng Fang, Hongwei Zhu, Kedan Chu. Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotypeMedical Oncology 2014; 31(12) doi: 10.1007/s12032-014-0327-7
11
Javed Akhtar, Ratna Priya, Vaishali Jain, Puja Sakhuja, Anil Kumar Agarwal, Surbhi Goyal, Ravindra Varma Polisetty, Ravi Sirdeshmukh, Sudeshna Kar, Poonam Gautam. Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinomaBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07676-6
12
Lanjing Zhang, Renee Frank, Emma E Furth, Amy F Ziober, Virginia A LiVolsi, Paul J Zhang. Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinomaExperimental Hematology & Oncology 2014; 3(1) doi: 10.1186/2162-3619-3-12
13
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_27-1
14
Ornuma Haonon, Rucksak Rucksaken, Porntip Pinlaor, Chawalit Pairojkul, Yaovalux Chamgramol, Kitti Intuyod, Sudarat Onsurathum, Narong Khuntikeo, Somchai Pinlaor. Upregulation of 14‐3‐3 eta in chronic liver fluke infection is a potential diagnostic marker of cholangiocarcinomaPROTEOMICS – Clinical Applications 2016; 10(3): 248 doi: 10.1002/prca.201500019
15
Ankit Halder, Deeptarup Biswas, Aparna Chauhan, Adrita Saha, Shreeman Auromahima, Deeksha Yadav, Mehar Un Nissa, Gayatri Iyer, Shashwati Parihari, Gautam Sharma, Sridhar Epari, Prakash Shetty, Aliasgar Moiyadi, Graham Roy Ball, Sanjeeva Srivastava. A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumorsClinical Proteomics 2023; 20(1) doi: 10.1186/s12014-023-09426-9
16
Juthamas Yosudjai, Chaturong Inpad, Phattarin Pothipan, Saowaluk Saisomboon, Damrasamon Surangkul, Suchada Phimsen, Nuttanan Hongsrichan, Sopit Wongkham, Siwanon Jirawatnotai, Sittiruk Roytrakul, Worasak Kaewkong. Overexpression of AGR2vH, an oncogenic AGR2 spliced transcript, potentiates tumorigenicity and proteomic alterations in cholangiocarcinoma cellBioscience, Biotechnology, and Biochemistry 2021; 85(11): 2263 doi: 10.1093/bbb/zbab156
17
Changping Zhou, Zhiyong Lin, Huanhuan Cao, Yue Chen, Jingxuan Li, Xiaofeng Zhuang, Dong Ma, Liang Ji, Wei Li, Suowen Xu, Bing Pan, Lemin Zheng. Anxa1 in smooth muscle cells protects against acute aortic dissectionCardiovascular Research 2022; 118(6): 1564 doi: 10.1093/cvr/cvab109
18
Viatcheslav A. Mordvinov, Galina A. Minkova, Anna V. Kovner, Dmitriy V. Ponomarev, Maria N. Lvova, Oxana Zaparina, Svetlana A. Romanenko, Alexander G. Shilov, Maria Y. Pakharukova. A tumorigenic cell line derived from a hamster cholangiocarcinoma associated with Opisthorchis felineus liver fluke infectionLife Sciences 2021; 277: 119494 doi: 10.1016/j.lfs.2021.119494
19
Yide Wong, Mark S. Pearson, Olga Fedorova, Vladimir Ivanov, Ekaterina Khmelevskaya, Bemnet Tedla, Buddhika Jayakody Arachchige, Sarah Reed, Matt Field, Thewarach Laha, Alex Loukas, Javier Sotillo. Secreted and surface proteome and transcriptome of Opisthorchis felineusFrontiers in Parasitology 2023; 2 doi: 10.3389/fpara.2023.1195457
20
Jinlian Wang, Yiming Zuo, Lun Liu, Yangao Man, Mahlet G. Tadesse, Habtom W. Ressom. Identification of Functional Modules by Integration of Multiple Data Sources Using a Bayesian Network ClassifierCirculation: Cardiovascular Genetics 2014; 7(2): 206 doi: 10.1161/CIRCGENETICS.113.000087
21
Kitti Intuyod, Napat Armartmuntree, Apinya Jusakul, Chadamas Sakonsinsiri, Raynoo Thanan, Somchai Pinlaor. Current omics-based biomarkers for cholangiocarcinomaExpert Review of Molecular Diagnostics 2019; 19(11): 997 doi: 10.1080/14737159.2019.1673162
22
Durkeshwari Anbalagan, Gracemary Yap, Yi Yuan, Vijay K. Pandey, Wai Hoe Lau, Suruchi Arora, Pradeep Bist, Justin S. B. Wong, Gautam Sethi, Peter M. Nissom, Peter E. Lobie, Lina H. K. Lim, Jun Li. Annexin-A1 Regulates MicroRNA-26b* and MicroRNA-562 to Directly Target NF-κB and Angiogenesis in Breast Cancer CellsPLoS ONE 2014; 9(12): e114507 doi: 10.1371/journal.pone.0114507
23
Xian-Di He, Yan Wang, Qiong Wu, Hua-Xue Wang, Zhen-Dong Chen, Rong-Sheng Zheng, Zi-Shu Wang, Jun-Bin Wang, Yan Yang. Xuebijing Protects Rats from Sepsis Challenged withAcinetobacter baumanniiby Promoting Annexin A1 Expression and Inhibiting Proinflammatory Cytokines SecretionEvidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/804940
24
Rachel M. Carnes, James A. Mobley, David K. Crossman, Hui Liu, Bruce R. Korf, Robert A. Kesterson, Deeann Wallis. Multi‐Omics Profiling for NF1 Target Discovery in Neurofibromin (NF1) Deficient CellsPROTEOMICS 2019; 19(11) doi: 10.1002/pmic.201800334
25
Chunbo Zhuang, Pei Wang, Ting Sun, Lei Zheng, Liang Ming. Expression levels and prognostic values of annexins in liver cancerOncology Letters 2019;  doi: 10.3892/ol.2019.11025
26
Zhuqiong Fu, Shanshan Zhang, Baiqi Wang, Weiguo Huang, Lulu Zheng, Ailan Cheng. Annexin A1: A double-edged sword as novel cancer biomarkerClinica Chimica Acta 2020; 504: 36 doi: 10.1016/j.cca.2020.01.022
27
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 501 doi: 10.1007/978-3-319-26956-6_27
28
Mohammad Zahid Mustafa, Viet Hung Nguyen, François Le Naour, Eleonora De Martin, Elvire Beleoken, Catherine Guettier, Catherine Johanet, Didier Samuel, Jean-Charles Duclos-Vallee, Eric Ballot. Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinomaJournal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-015-0751-2
29
Tonghui Cai, Xiaoying� Guan, Hongyan� Wang, Ying� Fang, Jie� Long, Xiaobin� Xie, Yajie� Zhang. MicroRNA‑26a regulates ANXA1, rather than DAL‑1, in the development of lung cancerOncology Letters 2018;  doi: 10.3892/ol.2018.8048
30
Lauren Kelly, Sarah McGrath, Lewis Rodgers, Kathryn McCall, Aysin Tulunay Virlan, Fiona Dempsey, Scott Crichton, Carl S. Goodyear. Annexin‐A1: The culprit or the solution?Immunology 2022; 166(1): 2 doi: 10.1111/imm.13455